|
March 05
Icoria announces board and
management changes
Monsanto Company to
acquire selected agricultural genomics assets from Icoria
-
Icoria to focus on
healthcare biotechnology, expects benefit of $15 million from
agriculture asset divestiture
-
Icoria reports Q4 and year-end results
February 05
Icoria signs licensing
agreement with Syngenta
Icoria receives seventh
U.S. patent on novel fungicide target
Icoria signs deal to
screen chemicals from DuPont Crop Protection to identify new
agricultural products
November 04
Icoria announces third
quarter 2004 financial results
October 04
Icoria expands
its fungicide patent portfolio
Icoria secures
$5 million in financing
Icoria expands
partnering with Agilent Technologies to include $11.7 million Advanced
Technology Program (ATP) grant for informatics research
September 04
Icoria now offers GLP
compliant gene expression profiling services through its Paradigm Array
Labs service unit
August 04
Paradigm Genetics
announces 2004 second quarter financial results
May 04
Paradigm Genetics adds two
more patents to its fungicides patent portfolio
April 04
Paradigm Genetics announces
2004 first quarter financial results
Paradigm Genetics
receives second U.S. patent for fungicide target pathway -
Discovery may lead to development of
more effective fungicides
March 04
Paradigm Genetics completes
acquisition of TissueInformatics, Inc., positioning itself as a systems
biology leader
February 04
Paradigm Genetics
announces 2003 fourth quarter and year end financial results
December 03
Paradigm Genetics signs
three-year, multi-million dollar crop trait collaboration agreement with
Pioneer Hi-Bred
November 03
Paradigm Genetics signs
fungicide evaluation agreement with Bayer CropScience - Screening tests
may lead to future licensing agreement
Paradigm signs two-year
extension of its herbicide discovery collaboration with Bayer
CropScience
August 03
Paradigm Genetics
announces 2003 second quarter financial results
May 03
Genes analyzed by Paradigm Genetics enter crop testing pipeline at
Monsanto
April 03
Paradigm Genetics announces
2003 first quarter financial results
Paradigm Genetics receives
extension from Nasdaq
March 03
Paradigm launches
microarray services business - Signs co-marketing agreement with Agilent
Technologies
Paradigm Genetics and its
collaborators announce the discovery of the role of heterotrimeric
G-protein signaling in plant cell proliferation and its association with
key agronomic traits
February 03
Paradigm Genetics
announces 2002 fourth quarter and year end financial results
January 03
Paradigm Genetics
receives NASDAQ notice of delisting
DNA LandMarks to acquire
plant genotyping business from Paradigm Genetics
November 02
Paradigm Genetics
announces third quarter 2002 financial results
August 02
Paradigm Genetics
announces second quarter 2002 financial results
July 02
Paradigm Genetics appoints Chief Executive Officer -- Dr. Heinrich
Gugger brings 20 years of management and scientific experience
May 02
Paradigm Genetics announces first quarter 2002 financial results
April 02
Paradigm Genetics completes
internal restructuring; new organization will better position company to
increase shareholder value
March 02
Paradigm Genetics announces
year end 2001 financial results, revenue increases 137 % over 2000 --
Company discusses its expansion into healthcare
February 02
Paradigm Genetics
announces management changes
Paradigm Genetics
delivers novel targets-based assays for developing herbicides to Bayer
AG
December 01
Celera and Paradigm
Genetics enter strategic alliance to offer genomic technologies to the
plant-based agricultural industry
(4011)
November 01
Paradigm Genetics
announces third quarter financial results
(3935)
October 01
Paradigm Genetics
closes $28 million direct offering of common stock
(3895)
Bayer AG
receives additional novel targets-based assays from Paradigm Genetics for
developing herbicides
(3883)
Paradigm Genetics
receives first technology patent
(3882)
September 01
Paradigm Genetics
exceeds fifth technical milestone in commercial partnership with
Monsanto; Monsanto amends agreement by removing termination clause
(3832)
Paradigm Genetics
and Bayer AG discover 250th herbicide targen in their
commercial partnership (3824)
August 01
Paradigm Genetics
develops comprehensive DNA microarrays for fungal pathogen of rice
(3728)
Paradigm Genetics
publishes first report detailing the similarity between two fungal
genomes
(3722)
Paradigm Genetics
processes millionth plant in GeneFunction Factory™ - New facility
fully operational (3718)
Bayer installs new
high-throughput assais from Paradigm Genetics
(3709)
Paradigm Genetics
announces second quarter financial results
(3699)
June
01
Paradigm
Genetics and Bayer AG extend commercial partnership on herbicides for
additional five years
(3593)
May
01
Bayer
AG accepts additional high-throughput assays from Paradigm Genetics
(3523)
April
01
Paradigm
Genetics announces first quarter financial results
(3493)
March
01
Paradigm Genetics
exceeds fourth consecutive technical milestone In
commercial partnership with Monsanto (3358)
February
01
Paradigm Genetics
announces year end 2000 financial results
(3300)
January
01
Bayer
accepts new high-throughput assays from Paradigm Genetics; New
assays based on novel targets identified by Paradigm
(3277)
December
00
Paradigm Genetics
discovers 100th herbicide target - Arabidopsis GeneFunction
Factory(TM) discovers novel, validated herbicide screening targets
faster than conventional methods
Paradigm Genetics
delivers new high-throughput screening assays to Bayer AG
(3177)
Paradigm Genetics
continues to surpass milestones in Monsanto collaboration
(3173)
November
00
Paradigm Genetics and LION Bioscience
expand new strategic alliance to co-develop and co-market metabolic profiling
database and bioinformatics software tools
(3124)
July
00
Paradigm Genetics
reaches gene function discovery throughput of 150 genes per week (2878)
June
00
Paradigm Genetics
applies industrialized gene function alteration to two major fungal
pathogens. Discoveries represent an important step in functional
analysis of key fungal targets
(2773)
January
00
Paradigm Genetics
enters into collaboration agreement with Monsanto for gene function
research
(2428)
LION Bioscience AG and Paradigm
Genetics, Inc. form strategic alliance In functional genomics
(2411)
November 99
Alexandria Real Estate
Equities and Paradigm Genetics break ground on center for functional genomics
research (2228)
June 99
Paradigm
Genetics selects Paracel's GeneMatcher for high-throughput data analysis (1837)
May 99
PE Biosystems
and Paradigm Genetics announce joint effort to develop next-generation genomics software
(N1826)
October 98
Bayer and
Paradigm Genetics cooperating in crop protection research (N1608)
. |
